Noxopharm Ltd has released a press release.
Pre-Clinical Breakthrough Discovery Set to Expand Pipeline
Filed with ASX ·
6ix hasn’t read this filing yet.
In the deck
Earlier from Noxopharm
- Noxopharm Completes A$23m Placement to Fund Clinical Studies
- Independent Discovery Validates DARRT Cancer Therapy
- Veyonda To Be Tested In Combination With Opdivo In Trial
- Dedicated Septic Shock Company Established
- Noxopharm Quarterly Activities Report & Appendix 4C
Later from Noxopharm
- NOXCOVID Study Advances
- Noxopharm Dec 2020 Quarterly Activities Report & Appendix 4C
- Major Survival Benefit in Prostate Cancer Patients Announced
- LuPIN Survival Outcome Confirmed by Conference Presentation
- Appendix 4D and Half Year Financial Report
Follow Noxopharm into a list and get an email when it puts out news.
Follow Noxopharm